Deliang Fu

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Zhihua Li · 2 shared papers, 2024–2025 · strength 0.33
   • Paper Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for … DOI 10.1186/s12916-025-04234-4↗
   • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
2. Tao Xia · 2 shared papers, 2024–2025 · strength 0.33
   • Paper Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for … DOI 10.1186/s12916-025-04234-4↗
   • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
3. Jichun Gu · 1 shared paper, 2026 · strength 0.27
   • Paper Extracellular vesicles from chemotherapy-induced senescent tumor cells reprogram hepatic phospholipid metabolism to pro… DOI 10.1186/s13046-026-03741-3↗
4. Baian Tao · 1 shared paper, 2026 · strength 0.27
   • Paper Extracellular vesicles from chemotherapy-induced senescent tumor cells reprogram hepatic phospholipid metabolism to pro… DOI 10.1186/s13046-026-03741-3↗
5. Huan Wang · 1 shared paper, 2025 · strength 0.18
   • Paper Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for … DOI 10.1186/s12916-025-04234-4↗
6. Xue Yang · 1 shared paper, 2025 · strength 0.18
   • Paper Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for … DOI 10.1186/s12916-025-04234-4↗
7. Xiaoyu Yin · 1 shared paper, 2025 · strength 0.18
   • Paper Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for … DOI 10.1186/s12916-025-04234-4↗
8. Tongsen Zheng · 1 shared paper, 2025 · strength 0.18
   • Paper Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for … DOI 10.1186/s12916-025-04234-4↗
9. Xianze Wang · 1 shared paper, 2025 · strength 0.18
   • Paper Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for … DOI 10.1186/s12916-025-04234-4↗
10. Qiang Xu · 1 shared paper, 2025 · strength 0.18
    • Paper Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for … DOI 10.1186/s12916-025-04234-4↗
11. Chuntao Gao · 1 shared paper, 2025 · strength 0.18
    • Paper Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for … DOI 10.1186/s12916-025-04234-4↗
12. Yuejuan Cheng · 1 shared paper, 2025 · strength 0.18
    • Paper Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for … DOI 10.1186/s12916-025-04234-4↗
13. Heshui Wu · 1 shared paper, 2025 · strength 0.18
    • Paper Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for … DOI 10.1186/s12916-025-04234-4↗
14. Rufu Chen · 1 shared paper, 2025 · strength 0.18
    • Paper Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for … DOI 10.1186/s12916-025-04234-4↗
15. Wenming Wu · 1 shared paper, 2025 · strength 0.18
    • Paper Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for … DOI 10.1186/s12916-025-04234-4↗
16. Chuntao Gao · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
17. Jiuwei Cui · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
18. Jun Yao · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
19. Jufeng Wang · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
20. Liwei Wang · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
21. Yuhong Zhou · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
22. Jiujie Cui · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
23. Shukui Qin · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.